Publication details
Postremission therapy for AML with intermediate risk cytogenetics in first complete remission.
Authors | |
---|---|
Year of publication | 2017 |
Type | Conference abstract |
MU Faculty or unit | |
Citation |
Go to main content | Go to main menu | Go to search
Authors |
VYDRA Jan SALEK C SCHWARZ J CETKOVSKÝ Petr ŽÁK Pavel NOVÁK Jan PETEČUKOVÁ Veronika MAYER Jiří RÁČIL Zdeněk |
---|---|
Year of publication | 2017 |
Type | Conference abstract |
MU Faculty or unit | |
Citation |